These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22889948)

  • 1. UA/NSTEMI: Are you following the latest guidelines?
    Dechant LM
    Nursing; 2012 Sep; 42(9):26-33; quiz 34. PubMed ID: 22889948
    [No Abstract]   [Full Text] [Related]  

  • 2. What's new in the UA/NSTEMI guidelines?
    Dechant LM
    Nursing; 2012 Dec; 42(12):69. PubMed ID: 23172071
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiplatelet agents in ischemic heart disease.
    May CH; Lincoff AM
    Handb Exp Pharmacol; 2012; (210):495-518. PubMed ID: 22918744
    [No Abstract]   [Full Text] [Related]  

  • 4. [Letter to Kardiologia Polska concerning optimal treatment of myocardial infarction].
    Grajek S
    Kardiol Pol; 2012; 70(2):213-4. PubMed ID: 22427099
    [No Abstract]   [Full Text] [Related]  

  • 5. [Optimal antiplatelet and antithrombotic therapy in patients with ST elevation myocardial infarction].
    Koziński M; Grześk G; Kubica J
    Kardiol Pol; 2012; 70(2):206-12. PubMed ID: 22427098
    [No Abstract]   [Full Text] [Related]  

  • 6. Controversies in acute cardiovascular care.
    Taylor J
    Eur Heart J; 2014 Mar; 35(9):535. PubMed ID: 24730030
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines.
    Antman EM
    Am Heart J; 2003 Oct; 146(4 Suppl):S18-22. PubMed ID: 14564302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considering the affordability of ticagrelor when used according to NICE guidance.
    Fell G; Reynolds B; Lindsay S; Keegan T; Lee D
    Int J Clin Pract; 2013 Nov; 67(11):1210-1. PubMed ID: 24165433
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].
    Silber S; Helms TM; Garlichs C; Arntz HR; Weil J; Ince H; Klingenheben T; Hoffmann S; Boudriot E; Steiger H; Zugck C
    Dtsch Med Wochenschr; 2011 Apr; 136(15):782-5. PubMed ID: 21432747
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet glycoprotein inhibitors in patients with medically managed acute coronary syndrome: does the enthusiasm exceed the science?
    Schriger DL; Herbert ME
    Ann Emerg Med; 2001 Sep; 38(3):249-55. PubMed ID: 11524643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future of oral antiplatelet therapy: four challenged hypotheses.
    Serebruany VL; Makarov LM
    Thromb Haemost; 2009 Jun; 101(6):1041-3. PubMed ID: 19492145
    [No Abstract]   [Full Text] [Related]  

  • 12. "Conversations in cardiology": How do you pick the best antiplatelet drug--clopidogrel, prasugrel, ticagrelor for your PCI patient?
    Kern MJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):255-62. PubMed ID: 22271555
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet GP IIb/IIIa inhibition in unstable angina and non-ST segment elevation MI: application of the ACC/AHA guidelines.
    Young JJ; Choo JK; Kereiakes DJ; ;
    J Invasive Cardiol; 2003 Feb; 15(2):102-7; quiz 108. PubMed ID: 12556626
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvement initiative.
    Bottorff MB; Nutescu EA; Spinler S
    Pharmacotherapy; 2007 Aug; 27(8):1145-62. PubMed ID: 17655514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What's new in antiplatelet and anticoagulant therapy recommendations for unstable angina/non-ST-elevation myocardial infarction: 2012 focused update from the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.
    Wenger NK;
    Clin Cardiol; 2012 Nov; 35(11):669-72. PubMed ID: 23070718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prasugrel offers consistent platelet control in appropriate patients requiring treatment.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(2):107, 109. PubMed ID: 21556460
    [No Abstract]   [Full Text] [Related]  

  • 17. Contemporary view of the acute coronary syndromes.
    Moustapha A; Anderson HV
    J Invasive Cardiol; 2003 Feb; 15(2):71-9. PubMed ID: 12556619
    [No Abstract]   [Full Text] [Related]  

  • 18. Meeting new challenges with antiplatelet therapy in primary care.
    Kuritzky L; Díez JG
    J Fam Pract; 2012 Jun; 61(6 Suppl):S22-8. PubMed ID: 22670232
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance to high-maintenance dose of prasugrel treated by ticagrelor: a case report.
    Xanthopoulou I; Stavrou EF; Kassimis G; Goudas P; Alexopoulos D
    Platelets; 2013; 24(3):239-41. PubMed ID: 22646854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.